Search

Your search keyword '"Nicca, D"' showing total 200 results

Search Constraints

Start Over You searched for: Author "Nicca, D" Remove constraint Author: "Nicca, D"
200 results on '"Nicca, D"'

Search Results

1. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland

2. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

3. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

4. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

5. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

6. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

7. Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study

8. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods

9. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

10. Associations Between Antiretroviral Treatment and Avascular Bone Necrosis: The Swiss HIV Cohort Study

12. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

13. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study

14. OP0212-HPR PATIENT ASSESSMENT CHRONIC ILLNESS CARE (PACIC) AND ITS ASSOCIATIONS WITH QUALITY OF LIFE AMONG SWISS PATIENTS WITH SYSTEMIC SCLEROSIS – A MIXED METHODS STUDY

15. A highly virulent variant of HIV-1 circulating in the Netherlands

17. Mining for pairs: shared clinic visit dates identify steady HIV‐positive partnerships

18. Ethnicity predicts viral rebound after travel to the tropics in HIV‐infected travelers to the tropics in the Swiss HIV Cohort Study

19. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

20. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

21. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

22. Children living with HIV in Europe: do migrants have worse treatment outcomes?

23. Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study

24. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

25. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study

26. Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals

27. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen

28. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

29. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

31. Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017

36. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

37. Height and timing of growth spurt during puberty in young people living with vertically acquired HIV in Europe and Thailand

38. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

39. Neglect of attention to reproductive health in women with HIV infection: contraceptive use and unintended pregnancies in the Swiss HIV Cohort Study

40. Guidelines

41. Starting or Changing Therapy - A Prospective Study Exploring Antiretroviral Decision-Making

42. The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals

43. Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012

44. Assessing efficacy of different nucleos(t)ide backbones in NNRTI-containing regimens in the Swiss HIV Cohort Study

45. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

46. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIRaben-1 subtype B and non-subtype B receiving a salvage regimen

47. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

48. Increases in Condomless Sex in the Swiss HIV Cohort Study

49. Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013

50. Reasons for not starting antiretroviral therapy in HIV-1-infected individuals: a changing landscape.

Catalog

Books, media, physical & digital resources